Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding
- 16 December 1996
- journal article
- Published by Elsevier in Brain Research
- Vol. 743 (1-2) , 178-183
- https://doi.org/10.1016/s0006-8993(96)01040-2
Abstract
No abstract availableKeywords
Funding Information
- Koninklijke Nederlandse Akademie van Wetenschappen
This publication has 22 references indexed in Scilit:
- Molecular pharmacological aspects of histamine receptorsPharmacology & Therapeutics, 1995
- Characterization of the binding of the first selective radiolabeled histamine H3‐receptor antagonist, [125I]‐iodophenpropit, to rat brainBritish Journal of Pharmacology, 1994
- Hypothalamo‐preoptic Histaminergic Projections in Sleep‐Wake Control in the CatEuropean Journal of Neuroscience, 1994
- Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonistEuropean Journal of Pharmacology, 1993
- Histamine H1 receptors in complex partial seizuresThe Lancet, 1993
- Histamine H3 receptors modulate the release of [3H]‐acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypesBritish Journal of Pharmacology, 1992
- The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: Saturable and reversible binding to rat cortex membranesEuropean Journal of Pharmacology, 1992
- The histamine H3-receptor: A target for developing new drugsPublished by Springer Nature ,1992
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983